U.S. markets open in 16 minutes

  • S&P Futures

    4,164.75
    +18.00 (+0.43%)
     

  • Dow Futures

    32,924.00
    +167.00 (+0.51%)
     

  • Nasdaq Futures

    13,265.25
    +36.50 (+0.28%)
     

  • Russell 2000 Futures

    1,933.40
    +11.60 (+0.60%)
     

  • Crude Oil

    87.55
    -1.46 (-1.64%)
     

  • Gold

    1,798.00
    +6.80 (+0.38%)
     

  • Silver

    20.25
    +0.41 (+2.08%)
     

  • EUR/USD

    1.0196
    +0.0008 (+0.08%)
     

  • 10-Yr Bond

    2.8050
    -0.0350 (-1.23%)
     

  • Vix

    21.42
    -0.02 (-0.09%)
     

  • GBP/USD

    1.2107
    +0.0036 (+0.30%)
     

  • USD/JPY

    134.8850
    -0.0850 (-0.06%)
     

  • BTC-USD

    24,077.29
    +936.76 (+4.05%)
     

  • CMC Crypto 200

    562.82
    +27.59 (+5.16%)
     

  • FTSE 100

    7,498.63
    +58.89 (+0.79%)
     

  • Nikkei 225

    28,249.24
    +73.37 (+0.26%)
     

Praxis Precision Posts Disappointing Data From Depression Study

  • Oops!
    Something went wrong.
    Please try again later.
Vandana Singh
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • PRAX

  • Praxis Precision Medicines Inc's (NASDAQ: PRAX) Phase 2/3 Aria Study of PRAX-114 for major depressive disorder (MDD) did not achieve statistical significance on the primary endpoint.

  • The primary endpoint was the change from baseline in the total score of the 17-item Hamilton Depression Rating Scale (HAM-D17).

  • The scale measures the frequency and intensity of depressive symptoms in individuals with major depressive disorder.

  • Praxis said it will prioritize programs in movement disorders and epilepsy moving forward.

  • Related: Praxis' PRAX-944 Shows Promising Action In Essential Tremor Patients.

  • The strategic realignment will result in a reduction of the company's workforce and future operating expenses. As a result of the realignment, the company's cash runway will extend into 2024.

  • The strategic alignment will focus on delivering Phase 2b results for PRAX-944 in essential tremor and proof-of-concept for PRAX-562 in epilepsy and advancing the pre-clinical pipeline.

  • Price Action: PRAX shares traded 65.1% lower at $3 premarket on the last check Monday.

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Recommended Stories

  • Bed Bath & Beyond's (NASDAQ:BBBY) Short Squeeze may be Risky, but the New Business Model has a Chance

    It seems that most of the bad performance of Bed Bath & Beyond ( NASDAQ:BBBY ) is attributable to the negative performance history after 2019. The stock is beaten down by short-selling, with some 35% of shares being shorted by July 14th, 2022, and analysts are also posting low price targets for the stock which has driven it to a multi-year low valuation.

  • Undervalued and Risky - Why Alibaba's (NYSE:BABA) Situation is Getting more Complicated

    Alibaba Group Holding Limited ( NYSE:BABA ) just released the latest earnings report for the quarter ending on June 30th, showing a noticeable business slowdown based on decreased commerce activity in China. In this analysis, we will pair the risk factors for Alibaba with the fundamentals in order to see if the market is skewed in any direction.

  • This Is, Hands Down, the Top Stock-Split Stock to Buy Right Now

    Alphabet, Amazon, DexCom, Shopify, and Tesla have all announced stock splits this year -- but only one of these giants is a screaming buy.

  • ‘We are in a recession’: Long-time bull Cathie Wood is warning investors about the ‘big problem’ in today's economy. Here are 3 stocks she likes now

    The super investor still sees opportunities ahead.

  • Pfizer Agrees to $5.4 Billion Deal for Global Blood Therapeutics

    Pfizer has agreed to buy Global Blood Therapeutics for $5.4 billion, a deal that will give the big drugmaker a foothold in the treatment of sickle-cell disease.

  • Winners and Losers in Democrats’ Signature Tax and Energy Bill

    (Bloomberg) -- President Joe Biden and Senate Majority Leader Chuck Schumer are the biggest winners now that a huge piece of Democrats’ economic agenda is hurtling toward enactment. Most Read from BloombergR Kelly Has $28,000 in His Prison-Inmate Account. Prosecutors Want to Seize ItBuffett’s Berkshire Pounces on Market Slump to Buy EquitiesTax Bill Latest: GOP Private Equity Carveout Amendment ApprovedWinners and Losers in Democrats’ Signature Tax and Energy BillThe tax and energy bill passed S

  • Palantir Stock Tumbles On Earnings Miss, Weak Revenue Outlook

    Palantir tumbled as earnings missed analyst estimates while revenue edged by Wall Street targets and guidance came in below views.

  • 1 Semiconductor Stock With 104% Upside, According to Wall Street

    Advanced Micro Devices continues to deliver strong financial results, which could lead to blockbuster gains in its stock price.

  • My bank accidentally deposited $10K in my account. I reported it, then moved it to my savings account. Have I done enough?

    ‘I have made an earnest attempt to get the bank to take their money back, so I was wondering if at any point or time the money would become legally mine.’

  • Tesla and 9 Other Companies That Would Take a Hit From a 15% Minimum Corporate Tax

    The tax would help fund the climate and healthcare deal proposed by Democrats. If it goes through, larger companies would bear the burden.

  • 3 Dirt Cheap High-Yield Dividend Stocks to Buy in August

    Whether the stock market is near an all-time high or in a bear market, no one wants to pay more for a share of a company than it is worth. A dirt cheap dividend stock could be a company that is being valued at less than its historical metrics indicate. Phillips 66 (NYSE: PSX), Kinder Morgan (NYSE: KMI), and United Parcel Service (NYSE: UPS) are three industry-leading businesses that are all cheap stocks based on historical valuations.

  • Macron pours hot water back into France’s rivers to avoid nuclear shutdown - live updates

    Britain really isn’t working – and the collapsing NHS is to blame Vegetable shortage looms as Europe battles heatwave FTSE 100 opens 0.6pc higher Roger Bootle: The Taiwan crisis is the stuff of economic nightmares Sign up here for our daily business briefing newsletter

  • Automakers say U.S. Senate bill will jeopardize 2030 EV targets

    WASHINGTON (Reuters) -A group representing General Motors, Toyota Motor, Volkswagen and other major automakers said a $430 billion bill approved Sunday by the U.S. Senate will put achieving U.S. electric-vehicle adoption targets for 2030 in jeopardy. "Unfortunately, the EV tax credit requirements will make most vehicles immediately ineligible for the incentive," said the Alliance for Automotive Innovation's chief executive, John Bozzella, adding the bill "will also jeopardize our collective target of 40-50% electric vehicle sales by 2030." The group had warned Friday that most EV models would not qualify for a $7,500 tax credit for U.S. buyers under the bill.

  • Over 100% Upside: Analysts See an Appealing Entry Point in These 3 ‘Strong Buy’ Stocks

    After July’s exceptional surge, the markets steadied during early August with the S&P 500 up by a third of a precent over the past week. Now investors will be keen to find out if the rally has legs. Stifel's chief equity strategist Barry Bannister thinks it does and believes the S&P 500 is on course to reach 4,400 during the year’s second half, explaining that the sell-off in 1H22 is “still being reversed.” The strategist also thinks the S&P 500’s “equity risk premium” now suggests a mid-point p

  • Despite high Earnings, Analysts may be Seeing Limited Upside for Exxon Mobil's (NYSE:XOM) Stock

    Exxon Mobil Corporation ( NYSE:XOM ) posted record Q2 earnings of $17.9b, amounting to $38.95 billion in the last 12 months. This marks a 227% YoY quarterly earnings growth. Investors that were bullish on XOM a year ago are getting a solid 60% return, however we need to analyze if the abnormal market conditions will persist - or if price tailwinds have reached their peak for this cycle.

  • Upstart Holdings Isn't a Stock to Hold on the Cusp of Earnings

    The charts and indicators of the operator of a cloud-based artificial intelligence lending platform are largely bearish.

  • Costco May Have a Huge Workers Problem

    Costco has famously been a good place to work. Costco has more than 13,000 ratings on the website, with 80% of employees recommending working at Costco. Over 2254 reviews even stated that they "love Costco because they provide you with a living wage and great benefits even working part time."

  • Jack Ma’s downfall is a symptom of Xi Jinping’s communist economy

    As a Chinese success story, Alibaba is unrivalled. As its founder, Jack Ma soared in power and prestige, acquiring a global reputation that spread alongside the company’s growth into a global e-commerce giant.

  • ‘Where you keep your savings is going to be very important.’ Pros predict when interest rates on savings accounts will rise, and where to find the best rates now

    While the recent Federal Reserve interest rate hikes likely sent groans through the pool of aspiring home and car buyers hoping to keep borrowing costs low, it may spell good news for some consumers: those hoping to earn a little more on their savings accounts. Indeed, past rate hikes have already benefited savers with interest rates rising on checking accounts, savings accounts and certificates of deposit (CDs), says NerdWallet’s banking specialist Chanelle Bessette. “Consumers can take advantage of these rate increases by shopping around for a new account, with better interest rates, especially since higher interest rates can help mitigate the effects of high inflation,” says Bessette.

  • Berkshire CEO-designate Abel sells stake in energy company he led for $870 million

    Berkshire Hathaway Inc said on Saturday that Vice Chairman Greg Abel, who is next in line to succeed billionaire Warren Buffett as chief executive, sold his 1% stake in the company's Berkshire Hathaway Energy unit for $870 million. In its quarterly report, Berkshire said the energy unit bought out Abel in June under an agreement among them and the family of the late billionaire philanthropist Walter Scott, which owns an 8% stake. Buffett's Omaha, Nebraska-based conglomerate took a $362 million charge to capital, reflecting the premium over how much the stake's value was reflected on its books.